Gilead Must Post $14M To Keep Ban On Generic Lexiscan
The Federal Circuit told Gilead that the drugmaker will have to post a bond of more than $14 million to keep a temporary injunction in place blocking Pfizer from launching a...To view the full article, register now.
Already a subscriber? Click here to view full article